39 Samples Failed In Quality Tests During June 2021: CDSCO

New Delhi : CDSCO has released an alert Notice for drug samples tested during June, 2021 by its regional laboratories. This list does not include the sample tested by state drug testing laboratories.

During this period samples of Ivermectin were tested manufactured by Psychotropics India Ltd, SIDCUL, Ranipur (Iverpil-12 Dispersible Tabs 12 mg) , which failed in Aerobic Microbial Count and another of Maan Pharmaceuticals Ltd, GIDC Phase-II, Mehsana, Ivermectin Tabs USP 6 mg, this fails in dissolution.

This is only the random sampling. This drug was widely prescribed during Covid Pandemic and gives a clear message that other batches of manufacturers available in the market were also failing in statutory tests.

Several Injectables were also found particulate matter eg Diclofenac Sod Inj IP 75 mg 3ml of Hindustan Antibiotics Ltd, Faridabad; Amikef-500-2ml( Amikacin Sulphate Inj IP) of Lupin Ltd, Vapi; Amikacin Sulphate Inj IP 500 mg/2 ml of Karnataka Antibiotics Ltd, Bengaluru; Sangenta Inj (Gentamicin Inj IP, 30 ml) of Jpee Drugs, SIDCUL, Haridwar; Sandexa Inj 30 ml (Dexamethasone Sod Phosphate Inj IP 2 mg/ml) of Jpee Drugs, SIDCUL, Haridwar; and Maxobal Inj  (Methylcobalamin, Pyridoxine HCl and Nicotinamide Inj ) of Havik Pharma, Sansarpur (HP)

One sample of Remdesivir for Inj 100 mg/vial (Covipri Inj) Purported to be manufacturerd by Pristine life Sciences, Sikkim also failed in Identification of Remdesivir, Particulate matter and Sterlity; which shows the sample to be spurious.

Two Samples  of Coldbest-PC Syrup manufactured by Digital Vision, Kala-Amb were found adulterated with Diethylene Glycol (DEG), which is contaminant in consumer products; this has resulted in numerous epidemics of poisoning since the early 20th century.

Several sample also failed in dissolution tests , assays and descriptions, which is serious concern.

It is also of serious concern that in market all ophthalmic drops are marketed in opaque containers. It is now proved fact that when injectables failed in particulate matter. It cannot be ruled out that an ophthalmic drop does not fail in particulate matter. Their opaque packing does not allow, analyst and public to check their contamination.

SOURCE : DrugsControl Media Services
  • Related Posts

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

    Ludhiana police seize 56 kg ganja; courier warehouse under scanner

    The recovery has raised serious concerns over alleged lapses in parcel screening and monitoring within the logistics chain. The special cell of Ludhiana police has seized more than two quintals…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise